---
title: Improve balance during dual tasking
nct_id: NCT06615115
phase: NA
status: RECRUITING
sponsor: Bahçeşehir University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06615115"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06615115"
last_fetched: "2026-05-10T14:06:29.544Z"
source: "Parkinson's Pathways (curated)"
---
# Improve balance during dual tasking

**Goal (in five words):** Improve balance during dual tasking

**Official Title:** Effects of an External and Combined Focus of Attention-Instructed Exercise Program on Postural Stability and Dual-Task Walking in Parkinson's Disease: A Randomized, Assessor-Blinded, Controlled Trial

**Trial ID:** [NCT06615115](https://clinicaltrials.gov/study/NCT06615115)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Bahçeşehir University
- **Target Enrollment:** 48 participants
- **Start Date:** 2025-01-30
- **Completion Date:** 2025-05-30
- **Conditions:** Parkinson Disease, Cognitive Deficit in Attention, Feedback, Psychological, Gait, Festinating
- **Interventions:** Exercise
- **Intervention Types:** OTHER

## Summary For Families

It aims to improve postural stability and walking while multitasking, the kinds of balance and dual-task problems that increase fall risk and cause festinating gait. The program uses guided exercises that teach an external and combined focus of attention, meaning people are cued to focus on movement outcomes or external targets instead of their body, which encourages more automatic motor control and steadier balance and gait under dual-task conditions. The trial is enrolling people aged 50 to 70 with mild to moderate Parkinson's, Hoehn and Yahr stage II or III, who walk independently but have balance issues, score 21,56 on the Berg Balance Scale and 24,30 on the MMSE, are in their medication-on period, and do not have freezing of gait, deep brain stimulators, dyskinesia, major neurological or sensory problems, or serious medical conditions.

## Eligibility

- **Minimum age:** 50 Years
- **Maximum age:** 70 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Hoehn and Yahr Stage II or III
* Individuals between the ages of 50 and 70 who can walk independently but have balance disorders
* Having a score between 21-56 on the Berg Balance Scale
* Having a score between 24-30 on the Mini Mental State Test
* Having agreed to participate in the study (Not having a freezing phenomenon)
* Being in the Medication-on period

Exclusion Criteria:

* Having malignancy and metabolic diseases
* Having had Cerebrovascular Accident before
* Other neurological disease history
* Presence of cognitive problems
* Presence of visual or hearing disorders
* Presence of deep brain pacemaker
* Presence of freezing phenomenon (persons with Freezing of Gait Questionnaire FOG-Q above zero)
* Presence of dyskinesia
```

## Locations (1)

- Atafiz Tıp Merkezi, Istanbul, Turkey (Türkiye) _(41.0138, 28.9497)_
  - Leyla Koçak, PT — (CONTACT) — +05334029807 — leyla.kocak2803@hotmail.com
  - İsmail Muştu, PT — (CONTACT) — +02165759444 — mustuismail@gmail.com

## Central Contacts

- Pelin Pişirici, PT, PhD — (CONTACT) — 05055016076 — pelinpisirici@gmail.com
- Selen Gür Özmen, MD — (CONTACT) — 05323941011 — selen.gur.ozmen@bau.edu.tr

---

*Canonical: https://parkinsonspathways.com/trial/NCT06615115*  
*HTML version: https://parkinsonspathways.com/trial/NCT06615115*  
*Source data: https://clinicaltrials.gov/study/NCT06615115*